Search research articles
Contact Us
Filters
Showing results (491-500 of 547) with videos related to
Page
of 55
Sort By:
JTO Clinical and Research Reports
|
September 16, 2024
Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced <i>ALK</i>-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA Study
Caicun Zhou, You Lu, Sang-We Kim, et al.
Translational Lung Cancer Research
|
May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than <i>EGFR</i>: a multicenter real-world analysis
Tian Tian, Yanying Li, Juan Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2019
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Yi-Long Wu, Shun Lu, Ying Cheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 2003
Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor
You Lu, Yu-quan Wei, Ling Tian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
Ligang Xing, Gang Wu, Luhua Wang, et al.
The Journal of Clinical Investigation
|
February 9, 2023
O-GlcNAc transferase in astrocytes modulates depression-related stress susceptibility through glutamatergic synaptic transmission
Jun Fan, Fang Guo, Ran Mo, et al.
Signal Transduction and Targeted Therapy
|
May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming
Laiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 15, 2021
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)
Ying Cheng, Tony S Mok, Xiangdong Zhou, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
May 21, 2023
Computational infrared and Raman spectra by hybrid QM/MM techniques: a study on molecular and catalytic material systems
Jingcheng Guan, You Lu, Kakali Sen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 21, 2023
A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities
Jingyao Chen, Siqi Dai, Lei Zhao, et al.
Page
of 55
Search research articles
Search
Showing results (491-500 of 547) with videos related to
Sort By:
Page
of 55
JTO Clinical and Research Reports
|
September 16, 2024
Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced <i>ALK</i>-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA Study
Caicun Zhou, You Lu, Sang-We Kim, et al.
Translational Lung Cancer Research
|
May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than <i>EGFR</i>: a multicenter real-world analysis
Tian Tian, Yanying Li, Juan Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 20, 2019
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
Yi-Long Wu, Shun Lu, Ying Cheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 2003
Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor
You Lu, Yu-quan Wei, Ling Tian, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
Ligang Xing, Gang Wu, Luhua Wang, et al.
The Journal of Clinical Investigation
|
February 9, 2023
O-GlcNAc transferase in astrocytes modulates depression-related stress susceptibility through glutamatergic synaptic transmission
Jun Fan, Fang Guo, Ran Mo, et al.
Signal Transduction and Targeted Therapy
|
May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programming
Laiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 15, 2021
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)
Ying Cheng, Tony S Mok, Xiangdong Zhou, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
May 21, 2023
Computational infrared and Raman spectra by hybrid QM/MM techniques: a study on molecular and catalytic material systems
Jingcheng Guan, You Lu, Kakali Sen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 21, 2023
A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their Susceptibilities
Jingyao Chen, Siqi Dai, Lei Zhao, et al.
Page
of 55